HC Wainwright Issues Pessimistic Forecast for Cartesian Therapeutics (NASDAQ:RNAC) Stock Price

Cartesian Therapeutics (NASDAQ:RNAC – Free Report) had its target price lowered by HC Wainwright from $45.00 to $40.00 in a report issued on Friday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. RNAC has been the subject of a number of other research reports. BTIG Research assumed coverage on shares of […]

Mar 17, 2025 - 06:42
 0
HC Wainwright Issues Pessimistic Forecast for Cartesian Therapeutics (NASDAQ:RNAC) Stock Price
Cartesian Therapeutics (NASDAQ:RNAC – Free Report) had its target price lowered by HC Wainwright from $45.00 to $40.00 in a report issued on Friday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. RNAC has been the subject of a number of other research reports. BTIG Research assumed coverage on shares of […]